David Aviezer
Chairman at Metabomed Ltd.
Profile
David Aviezer is currently the Chairman of Metabomed Ltd.
He was previously the President & Chief Executive Officer of Orthodontix, Inc. from 2006 to 2007 and the President, Chief Executive Officer & Director of Protalix Biotherapeutics, Inc. from 2010 to 2014.
Dr. Aviezer has an undergraduate degree and an MBA from Bar-Ilan University and a graduate degree and doctorate from Weizmann Institute of Science.
David Aviezer active positions
| Companies | Position | Start |
|---|---|---|
Metabomed Ltd.
 Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | Chairman | - |
Former positions of David Aviezer
| Companies | Position | End |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Chief Executive Officer | 01/11/2014 |
| Orthodontix, Inc. | President | 28/02/2007 |
Training of David Aviezer
| Weizmann Institute of Science | Doctorate Degree |
| Bar-Ilan University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Orthodontix, Inc. | Finance |
Metabomed Ltd.
Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | Health Technology |
- Stock Market
- Insiders
- David Aviezer
